Led · Seed · Jul 2026

Dopl Technologies develops a distributed telerobotic ultrasound ecosystem that includes Traverse (a remote robotic ultrasound system), Dopl Connect (a secure connectivity and data platform), and SonoFlex (a distributed clinical workforce and workflow management solution). The company also operates an interim service, CareBridge, which provides traveling sonographer coverage and has delivered up to a 90% reduction in patient wait times where it operates. Dopl has completed FDA pre-submission engagement, established a 510(k) regulatory pathway, and holds patented technology. The business estimates a significant market opportunity, citing a roughly $40 billion annual reimbursement opportunity for U.S. hospitals as telerobotic imaging scales. With more than $8 million in total funding following its $6.3 million seed, Dopl is pursuing product verification, clinical evaluation, regulatory clearance, and initial pilot deployments. The team, founded in 2022 and headquartered in Bothell, includes clinicians and engineers with experience from organizations such as Butterfly Network, Philips, Microsoft, Amazon, and NVIDIA.

Participated · Series C · Apr 2026

Tava Health operates a technology-driven behavioral health platform that connects clinicians, employers, and health plans and offers tools across the care lifecycle. The company recently launched Symphony by Tava Health, an AI-assisted practice management system for clinicians; TavaCare for Employers, which can be fully sponsored or used with existing insurance without per-employee fees; and Tava Guide, a referral and care-tracking hub for payers and systems. Tava reports integrations with more than 200 health plans and claims in-network reach for nine in 10 commercially insured Americans, with first-session availability in as little as 12 hours. It also reports that 87% of its clients show measurable clinical improvement. The company says its platform is designed to reduce administrative burden for clinicians while removing cost barriers for employers. The new Series C funding will support deeper investment in partners and continued platform expansion.

Participated · Series A · Dec 2025

Wearlinq is a San Francisco–based digital health company focused on bringing clinical-grade cardiac diagnostics out of the clinic through its flagship product, eWave. The eWave device is a 6-lead, wireless cardiac monitor that connects to a patient’s personal phone, operates for more than five days between charges, and provides clinicians with near-real-time data and diagnostic reports within 48 hours. The product has received FDA 510(k) clearance and is already deployed across thousands of patients for arrhythmia detection. Management plans to expand the platform’s indications beyond arrhythmia to broader heart-failure management and remote patient monitoring. By leveraging consumer-friendly hardware and cloud analytics, the company aims to lower costs and increase accessibility to cardiac care. The fresh capital positions Wearlinq to scale commercialization, enhance its data platform, and pursue additional clinical validations.

Participated · Series A · Nov 2025

IgniteData develops Archer, a platform that automates the movement of clinical trial data from source systems such as electronic health records (EHRs) to electronic data capture (EDC) systems and data warehouses. The technology reduces site burden, improves data quality and accelerates trial timelines by combining intelligent data mapping with generative AI. Following its recent financing, the company plans to expand its global research site network and deepen its work with large language models to unlock previously inaccessible clinical data. IgniteData collaborates with premier research centers and top pharmaceutical sponsors, positioning itself as a critical bridge between healthcare providers and life-science companies. Capital from the Series A will fund further product advancement and global scaling efforts. Although revenue or user metrics were not disclosed, the oversubscription of the round signals strong market demand and investor confidence.

Participated · Convertible Note · Jan 2025

ThreatMark provides a fraud prevention platform that continuously monitors behavioral, device, threat, and transactional data to detect deviations that signal potential fraudulent activity in real time. The platform uses AI and machine learning to identify known fraud patterns and adapt to emerging threats as it processes new data. Its primary customers are banks and participants in the financial services ecosystem. Led by CEO Michal Tresner and CTO Krystof Hilar, the company plans to use recent funding to expand market reach (including the UK and US), accelerate research and development, and enhance solution capabilities. Over the past 12 months ThreatMark has achieved a 75% year-over-year ARR increase. The company has raised $37 million in total funding since its founding. ThreatMark develops behavior-based fraud prevention solutions and positions itself as a market innovator. The company says the latest funds will be used to advance research and development, expand market reach, and enhance product capabilities. ThreatMark is nearing the end of a year with over 50% year-over-year revenue growth. Over the past 12 months the company has secured more than $13 million in cumulative funding, with Springtide Ventures leading that group of investors. Management framed the fundraising as a vote of confidence in the company’s vision and execution amid a challenging funding environment. ThreatMark plans to leverage investor support to accelerate growth in the fraud prevention market. ThreatMark is a Prague-based provider of advanced online fraud prevention built on AI and cybersecurity expertise. Its core product uses AI-powered behavior profiling, advanced behavioral biometrics, and real-time transaction risk monitoring and analysis to detect and prevent sophisticated digital fraud. The platform processes a comprehensive set of data to continuously monitor user identities and intentions across digital channels, with a focus on financial services and other major online businesses. The company appointed Daniel Rawlings as CEO & President while co-founder Michal Tresner continues as Chairman and Chief Product Officer and co-founder Kryštof Hilar remains CTO. ThreatMark completed a new $3M funding round led by Springtide Ventures. Management says the capital and leadership changes will support expansion and growth, with an initial emphasis on Europe and North America.